Development Level

Tbio 10 | 10,625
Tdark 1 | 7,003

Disease

Endometriosis 7 | 535
colon cancer 7 | 1,475
intraductal papillary-mucinous adenoma (IPMA) 7 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 7 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,289
lung cancer 7 | 4,473
medulloblastoma, large-cell 7 | 6,234
non-small cell lung cancer 7 | 2,798
ovarian cancer 7 | 8,491
ulcerative colitis 7 | 2,087
acute quadriplegic myopathy 6 | 1,157
atypical teratoid/rhabdoid tumor 6 | 1,095
cystic fibrosis 6 | 1,670
malignant mesothelioma 6 | 3,163
osteosarcoma 6 | 7,933
pancreatic cancer 6 | 2,300
active Crohn's disease 5 | 918
lung adenocarcinoma 5 | 2,714
primary pancreatic ductal adenocarcinoma 5 | 1,271
psoriasis 5 | 6,685
adrenocortical carcinoma 4 | 1,427
sonic hedgehog group medulloblastoma 4 | 1,482
Bladder Neoplasm 3 | 109
Breast cancer 3 | 3,098
Down syndrome 3 | 548
breast carcinoma 3 | 1,614
glioblastoma 3 | 5,572
group 3 medulloblastoma 3 | 2,254
invasive ductal carcinoma 3 | 2,950
lung carcinoma 3 | 2,844
Cancer 2 | 2,346
Liver carcinoma 2 | 217
Neoplasm Invasiveness 2 | 127
cutaneous lupus erythematosus 2 | 1,056
facioscapulohumeral dystrophy 2 | 286
inflammatory breast cancer 2 | 404
interstitial cystitis 2 | 2,299
nephrosclerosis 2 | 329
primitive neuroectodermal tumor 2 | 3,031
Alzheimer's disease 1 | 644
Arsenic Poisoning 1 | 59
Cardiomegaly 1 | 66
Esophageal Neoplasms 1 | 67
Heart Diseases 1 | 42
Hepatitis, Chronic 1 | 22
Impulse control disorder 1 | 3
Inverted papilloma 1 | 8
Kidney Diseases 1 | 86
Lead Poisoning 1 | 6
Liver Cirrhosis, Experimental 1 | 108
Lymphatic Metastasis 1 | 14
Mammary Neoplasms 1 | 410
Mouth Neoplasms 1 | 44
Pick disease 1 | 1,893
Prostatic Intraepithelial Neoplasias 1 | 11
Prostatic Neoplasms 1 | 471
Seizures 1 | 95
Squamous cell carcinoma 1 | 96
Stomach Neoplasms 1 | 282
Wernicke-Korsakoff syndrome 1 | 8
adrenocortical adenoma 1 | 134
adult high grade glioma 1 | 2,148
astrocytic glioma 1 | 2,241
astrocytoma 1 | 1,493
atypical teratoid / rhabdoid tumor 1 | 4,369
dermatomyositis 1 | 966
diabetes mellitus 1 | 1,663
ductal carcinoma in situ 1 | 1,745
ependymoma 1 | 2,514
esophageal adenocarcinoma 1 | 737
head and neck cancer 1 | 270
hereditary spastic paraplegia 1 | 313
mucosa-associated lymphoid tissue lymphoma 1 | 480
non-small cell lung carcinoma 1 | 413
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pituitary cancer 1 | 1,972
spina bifida 1 | 1,064
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis and treatment for 6 months 1 | 686

Tissue

Cardiovascular System 11 | 17,957
Digestive Tract 11 | 18,472
Endocrine System 11 | 18,511
Female tissues 11 | 18,646
Liver and Pancreas 11 | 18,135
Nervous System 11 | 18,560
Skin and soft tissues 11 | 18,114
Urinary Tract 11 | 18,443
Male tissues 10 | 17,968
Respiratory system 10 | 17,483
Blood and immune system 9 | 17,994

Target Family

Non-IDG 11 | 11,969

Reactome Pathway

Metallothioneins bind metals 11 | 11
Signal Transduction 2,515 | 2,515
Immune System 2,183 | 2,183
Metabolism 2,131 | 2,131
Gene Expression 1,754 | 1,754
Metabolism of proteins 1,544 | 1,544
Innate Immune System 1,375 | 1,375
Signaling by GPCR 1,329 | 1,329
Developmental Biology 1,028 | 1,028
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,004 | 1,004
Adaptive Immune System 938 | 938
Disease 855 | 855
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 803 | 803
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 668 | 668
Membrane Trafficking 608 | 608
Cell Cycle 572 | 572
Neutrophil degranulation 542 | 542
Axon guidance 541 | 541
Signaling by Interleukins 500 | 500
Cell Cycle, Mitotic 470 | 470
Signalling by NGF 467 | 467
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 435 | 435
Class I MHC mediated antigen p... 430 | 430
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 423 | 423
Cellular responses to stress 415 | 415
DAP12 interactions 409 | 409
Infectious disease 391 | 391
NGF signalling via TRKA from t... 378 | 378
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 367 | 367
Diseases of signal transductio... 359 | 359
Transcriptional Regulation by ... 356 | 356
Signaling by EGFR 355 | 355
Metabolism of amino acids and ... 353 | 353
DAP12 signaling 346 | 346
Downstream signal transduction 343 | 343
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 329 | 329
Signaling by SCF-KIT 327 | 327
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 321 | 321
FCERI mediated MAPK activation 316 | 316
Signaling by Insulin receptor 312 | 312
Antigen processing: Ubiquitina... 301 | 301
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 290 | 290
Signaling by Wnt 290 | 290
IGF1R signaling cascade 289 | 289
IRS-related events triggered b... 289 | 289
Insulin receptor signalling ca... 288 | 288
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 285 | 285
MAPK family signaling cascades 283 | 283
Asparagine N-linked glycosylat... 282 | 282
Signaling by the B Cell Recept... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 277 | 277
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 268 | 268
M Phase 266 | 266
Interleukin-3, 5 and GM-CSF si... 262 | 262
RET signaling 261 | 261
Signalling to ERKs 254 | 254
Interleukin-2 signaling 253 | 253
Immunoregulatory interactions ... 252 | 252
RHO GTPase Effectors 249 | 249
VEGFR2 mediated cell prolifera... 249 | 249
Signalling to RAS 247 | 247
Interleukin receptor SHC signa... 246 | 246
G alpha (i) signalling events 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Signaling by Leptin 244 | 244
Prolonged ERK activation event... 243 | 243
MAPK1/MAPK3 signaling 242 | 242
Frs2-mediated activation 241 | 241
HIV Infection 241 | 241
ARMS-mediated activation 240 | 240
Signalling to p38 via RIT and ... 240 | 240
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 236 | 236
RAF/MAP kinase cascade 236 | 236
SHC1 events in EGFR signaling 236 | 236
SOS-mediated signalling 236 | 236
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Phospholipid metabolism 202 | 202

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Metallothionein-1F MT1F Tbio Non-IDG -1.13298 14.0 4
Metallothionein-1A MT1A Tbio Non-IDG -1.99723 95.9 34
Metallothionein-1E MT1E Tbio Non-IDG -1.42780 40.1 28
Metallothionein-3 MT3 Tbio Non-IDG -2.29595 191.8 79
Metallothionein-4 MT4 Tbio Non-IDG -1.56941 34.9 4
Metallothionein-1M MT1M Tdark Non-IDG -1.18435 13.6 4
Metallothionein-1X MT1X Tbio Non-IDG -1.27542 19.5 14
Metallothionein-1H MT1H Tbio Non-IDG -1.25191 29.2 4
Metallothionein-1B MT1B Tbio Non-IDG -1.14032 13.2 4
Metallothionein-2 MT2A Tbio Non-IDG -2.43368 259.2 92